
MIG Capital AG is a Munich-based venture capital firm and Germany's only retail VC, founded in 2004. It invests in early-stage deep tech and life sciences companies across German-speaking Europe and beyond, with over €750 million deployed in approximately 55 companies.
Average disclosed round size is $27.5M (across 9 rounds with reported amounts).
Portfolio
23
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Dr. Matthias Kromayer
Managing Partner
Jürgen Kosch
Managing Partner
Andreas Kastenbauer, MBA
Partner
Dr. Oliver Kahl
Partner
Matthias Guth
Venture Partner
Dr. Fei Tian
Principal
Dr. Nicolas Rose-André
Principal
Frederick Michna
Principal
Christina Vogt-Sasse
SENIOR ASSOCIATE
Anna Wiedemann
Team Assistant
Barbara Steingruber-Dotterweich
Office Manager
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | — | Jul 2026 | |
| Seed | — | Nov 2025 | |
| Seed | — | Jul 2025 | |
| LLookup | Series A | $53.9M | Jun 2025 |
| Unknown | — | Jan 2025 | |
| LLook Up | Series A | — | Jan 2025 |
| Series A | — | Jul 2024 | |
| Series A | $21M | Jun 2024 | |
| IInnatera | Series A | $21M | Mar 2024 |
| AAMSilk GmbH | Series C | — | Apr 2023 |
| Seed | — | Jan 2023 | |
| AAMSilk GmbH | Unknown | — | Jan 2023 |
| Series C | $75M | Dec 2022 | |
| Series A | $20M | Dec 2020 | |
| Seed | — | Jul 2019 | |
| Series B | — | Feb 2019 | |
| Series A | $7.5M | Apr 2016 | |
| Series B | — | — | |
| Series B | — | — | |
| Series A | $6M | — | |
| Unknown | $40M | — | |
| Growth | — | — | |
| TTibeay Biosciences | Unknown | — | — |
| Series A | — | — | |
| Seed | $3.2M | — |
Top Co-Investors
Last updated: 14 September 2026